Science Explorer Back to mapMap
Discussion
Researcher · Bexion Pharmaceuticals (United States) · United States

Tariq Arshad

Tariq Arshad publishes mostly in Molecular Biology, Oncology and Cancer Research, on topics such as Advanced biosensing and bioanalysis techniques, RNA Interference and Gene Delivery and Sphingolipid Metabolism and Signaling.

OpenAlex
World rank
#2,540,787
of 7,710,434 ranked researchers
Rank in United States
#747,552
of 1,627,098
Works
40
Citations
325
Citations per work
8.1
h-index
4
i10-index 3Top 98% in Molecular Biology
Tariq Arshad

What does Tariq Arshad research?

Tariq Arshad's work is mostly in Biochemistry, Genetics and Molecular Biology (60%), Medicine (13%), Engineering (3%).

Life Sciences: 24 works · 59.7% of their workBiochemistry, Genetics and Molecular Biology: 24 works · 59.7% of their workMolecular Biology: 20 works · 50.0% of their workCancer Research: 2 works · 5.3% of their workCell Biology: 2 works · 4.4% of their workEverything else: 10 works · 24.6% of their workHealth Sciences: 5 works · 13.1% of their workMedicine: 5 works · 13.1% of their workOncology: 4 works · 9.6% of their workPulmonary and Respiratory Medicine: 1 works · 3.5% of their workPhysical Sciences: 1 works · 2.6% of their workEngineering: 1 works · 2.6% of their workBiomedical Engineering: 1 works · 2.6% of their workTHEIR WORKTariq Arshad40works
Life Sciences60%Physical Sciences3%Health Sciences13%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology2459.7%
  2. Everything else1024.6%
    1. Medicine513.1%
    1. Engineering12.6%
  1. 1Molecular Biology50% of their works
  2. 2Oncology10% of their works
  3. 3Cancer Research5% of their works
  4. 4Cell Biology4% of their works
  5. 5Pulmonary and Respiratory Medicine4% of their works
  6. 6Biomedical Engineering3% of their works

Research topics

Which keywords describe Tariq Arshad's research?

The keywords of their largest research topics: Cancer, Gene Therapy, DNA nanotechnology, Self-Assembly, RNA Interference, siRNA Delivery, Sphingolipids and Sphingosine-1-Phosphate.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Cancer172 topics
  2. Gene Therapy152 topics
  3. DNA nanotechnology131 topic
  4. Self-Assembly131 topic
  5. RNA Interference121 topic
  6. Sphingolipids121 topic
  7. Sphingosine-1-Phosphate121 topic
  8. siRNA Delivery121 topic
  9. DNA Structure91 topic
  10. G-Quadruplexes91 topic
  11. Chemotherapy-Induced Peripheral Neuropathy51 topic
  12. Fatty Acid Synthase51 topic
  13. Lipid Metabolism51 topic
  14. Taxanes51 topic
  15. Caveolae41 topic
  16. Caveolin41 topic
  17. Bacterial Therapy31 topic
  18. Tumor Targeting31 topic

Where does Tariq Arshad work?

Tariq Arshad's main affiliation in the publication record is Bexion Pharmaceuticals (United States), United States.

How many publications and citations does Tariq Arshad have?

OpenAlex counts 40 works and 325 citations for Tariq Arshad, an h-index of 4, ranking #2,540,787 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Tariq Arshad. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.